- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02400541
Efficacity of Cognitive Remediation Treatment Compared to a Controlled Group in Young Patient With Anorexia Nervosa (RECOGAMEA)
Prospective Evaluation of Neuropsychological and Clinical Impact of Cognitive Remediation Program Among Children and Adolescents Treated for Anorexia Nervosa
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In this research, the investigators want to evaluate remediation cognitive therapy in anorexia nervosa compared to a controlled group (relaxation) based on different factors that testified the cognitive improvement of patients: one week after therapy, six months after and one year after.
Those factors are:
Weight, perfectionism and food symptomatology, temperament, therapeutic alliance and change motivation, clinical evolution of anorexia nervosa, self esteem, executive functions, neuropsychological performance (flexibility and central coherence).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75019
- Asch
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Pathology
- DSM IV criteria of restrictive anorexia nervosa (AN- R), but not requiring amenorrhea or DSM V
- Accepting and their parents to participate in the study ( signed consents )
Topics
- Female supported for AN- R
- Aged 8 to 16 years
- Fluent French
- Inpatients or outpatients suffering of restrictive anorexia nervosa
Treatments
- Supports standard load ( family psychotherapy , dietary management , medical monitoring )
- In case of anxiety or depression , patients may receive additional psychotropic prescription which should be mentioned in the record
- Treatments previously followed by patients and treatments for other conditions should be described
Exclusion Criteria:
Pathology
- Mental Retardation
- Schizophrenia
- Organic brain disorder ( encephalitis , degenerative brain tumor , cerebral neuro- degenerative disease , multiple sclerosis , amyotrophic lateral sclerosis, epilepsy )
- Metabolic Pathology interfere with feeding or its regulation
- Trouble consumption current substance
- Severe somatic pathology , progressive or likely to be life -threatening
Topics The subjects are not mastering the French language will not be considered
- Subjects or parents do not have sufficient capacity for understanding instructions and consent
- No affiliation in social security ( beneficiary or legal )
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive remediation therapy
10 sessions of the cognitive remediation therapy program conducted during five weeks
|
Our scheme comprises 10 biweekly sessions ( 5 in group and 5 single) . Each session last about 45 minutes. Individual sessions will be held with the patient and a therapist trained in the CRT; group sessions will be led by two therapists trained in CRT and regroup the maximum 5 patients. |
|
Placebo Comparator: relaxation therapy
10 relaxation sessions during 5 weeks
|
Our scheme comprises 10 biweekly sessions.
Each session last about 45 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cognitive flexibility
Time Frame: 6 months after therapy
|
behavioral characteristics related to cognitive difficulties flexibility of anorexic patients, as measured in the medium term (6 months post treatment) by the score of the subscale "shift" BRIEF parent version of the scale (BRIEF-PR).
|
6 months after therapy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight status
Time Frame: 6 months and one year
|
Assess the impact of cognitive remediation therapy on :Weight status by the Body Mass Index
|
6 months and one year
|
|
Food symptoms and perfectionism
Time Frame: 6 months and one year
|
Assess the impact of cognitive remediation therapy on :Food symptoms and perfectionism measured by the Eating Disorders Inventory auto questionnaire, EDI-2
|
6 months and one year
|
|
Temperamental profile
Time Frame: 6 months after therapy
|
Assess the impact of cognitive remediation therapy on :Temperamental profile measured by the Junior Temperament and Character Inventory questionnaire
|
6 months after therapy
|
|
Therapeutic alliance and motivation to change
Time Frame: 6 months and one year
|
Assess the impact of cognitive remediation therapy on : therapeutic alliance and motivation to change measured by self-reported scales Helping Alliance Questionnaire-11 and MOTIV
|
6 months and one year
|
|
Self-esteem
Time Frame: 6 months and one year
|
measured by the Rosenberg Self-Esteem Scale
|
6 months and one year
|
|
Executive functions
Time Frame: 6 months and one year
|
measured by the scale BRIEF-Parent Report
|
6 months and one year
|
|
Neuropsychological performance in particular flexibility and central coherence
Time Frame: 6 months and one year
|
measured by tests of WCST (Wisconsin Card Sorting Test), Geft (Group Embedded Figure Test) and tests the battery Ravello Profile (Tower, Verbal Fluency Test VFT, Trail Making Test TMT, Rey Complex Figure Test Osterreich ROCFT )
|
6 months and one year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Asch Muriel, PHD, -Hôpital Robert Debré, Service de psychiatrie de l'enfant et de l'adolescent
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P130905
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anorexia Nervosa
-
Baylor College of MedicineEnrolling by invitationAnorexia Nervosa | Atypical Anorexia NervosaUnited States
-
Rosemary Claire RodenChildren's Miracle NetworkTerminatedBulimia Nervosa | Impulsive Behavior | Purging (Eating Disorders) | Eating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa, Binge Eating/Purging TypeUnited States
-
University of California, San DiegoActive, not recruitingAnorexia Nervosa | Bulimia Nervosa | Atypical Anorexia Nervosa | Atypical Bulimia NervosaUnited States
-
University of California, San DiegoRecruitingAnorexia Nervosa | Bulimia Nervosa | Anorexia Nervosa in RemissionUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Fundació La Marató de TV3RecruitingAnorexia Nervosa | Anorexia Nervosa in Remission | Anorexia Nervosa Restricting TypeSpain
-
Duke UniversityCompletedAdolescent Anorexia Nervosa | Subthreshold Anorexia NervosaUnited States
-
Stanford UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH) and other collaboratorsCompletedAnorexia Nervosa | Anorexia | Eating Disorder | Eating Disorders in Adolescence | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa Restricting Type | Anorexia in ChildrenUnited States
-
Istituto Auxologico ItalianoCatholic University of the Sacred Heart; University of Turin, Italy; Open University and other collaboratorsRecruitingAnorexia Nervosa/BulimiaItaly
-
University Hospital, MontpellierCompleted
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsEnrolling by invitationAtypical Anorexia NervosaUnited States
Clinical Trials on Cognitive remediation therapy
-
Yale UniversityCompletedCancer | Cancer of the ProstateUnited States
-
Gemma Garrido GarcíaCompleted
-
Fundació Sant Joan de DéuCompletedIndication for Modification of Patient Cognitive StatusSpain
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Mental DisordersUnited States
-
Beykoz UniversityUskudar University; Istanbul Nisantasi UniversityRecruitingCognitive Dysfunction | Schizophrenia Disorders | Emotion Regulation DisordersTurkey
-
South London and Maudsley NHS Foundation TrustCompleted
-
Fraser HealthMinistry of Social Development and Poverty Reduction, British ColumbiaCompletedSchizophrenia and Related Disorders | Psychotic DisorderCanada
-
The Royal Ottawa Mental Health CentreNot yet recruiting
-
Centre for Addiction and Mental HealthCompletedSchizophrenia | Cognitive Deficit | Cognitive Remediation | Functional Impairment | Late Life SchizophreniaCanada
-
King's College LondonUnknownSchizophrenia Schizoaffective